Oral delivery product
Latest Pfizer Inc. Patents:
- CDCP1 antibodies and antibody drug conjugates
- Pyrrolo[2,3-d]pyrimidinyl, Pyrrolo[2,3-b]pyrazinyl and Pyrrolo[2,3-d]pyridinyl Acryla-mides
- CRYSTAL-FREE HIGH-CONCENTRATION TESTOSTERONE CYPIONATE FORMULATIONS
- Dosing Regimen of Avelumab for the Treatment of Cancer
- 3-indol substituted derivatives, pharmaceutical compositions and methods for use
Description
Claims
The ornamental design for an oral delivery product, as shown and described.
Referenced Cited
Patent History
Patent number: D748240
Type: Grant
Filed: Oct 21, 2014
Date of Patent: Jan 26, 2016
Assignee: Pfizer Inc. (New York, NY)
Inventor: Michael A. Goode (Powhatan, VA)
Primary Examiner: Susan Bennett Hattan
Assistant Examiner: Charles Hanson
Application Number: 29/506,871
Type: Grant
Filed: Oct 21, 2014
Date of Patent: Jan 26, 2016
Assignee: Pfizer Inc. (New York, NY)
Inventor: Michael A. Goode (Powhatan, VA)
Primary Examiner: Susan Bennett Hattan
Assistant Examiner: Charles Hanson
Application Number: 29/506,871
Classifications
Current U.S. Class:
Tablet Or Caplet (1) (D24/101)